Healthcare / Medical - Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

AIM/CLBX stock hub

AIM/CLBX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/CLBXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

11.6M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/CLBX

In the news

Latest news · AIM/CLBX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-87.2

P25 -54.2P50 2.1P75 13.7

ROIC-46.3

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/CLBX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

181

Groups with data

Currency

GBP

Showing 181 of 181 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	119
Employees Change	-31%
Employees Change Percent	-20.67
Enterprise value	GBX 10M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Medical - Diagnostics & Research
Isin	GB0034330679
Last refreshed	2026-05-10
Market cap	GBX 11.6M
Price	GBX 1.07
Price currency	GBX
Rev Per Employee	22,050.42x
Sector	Healthcare
Sic	3845
Symbol	aim/CLBX
Website	https://cellbxhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-135.47%
EV Earnings	-0.64x
EV/FCF	-0.86x
EV/Sales	3.83x
FCF yield	-99.76%
P/B ratio	1x
P/S ratio	4.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	31.36%
Gross Profit	GBX 823,000
Gross Profit Growth	-14.98%
Gross Profit Growth Q	-23.73%
Net Income	GBX -15.8M
Pretax Margin	-629%
Profit Per Employee	GBX -132,605
ROA	-39.98
Roa5y	-28.65
ROCE	-109.4
ROE	-87.18
Roe5y	-52.98
ROIC	-46.31

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-33.93%
Cagr15y	-19.11%
Cagr1y	-87.3%
Cagr20y	-19.55%
Cagr3y	-62.47%
Cagr5y	-60.66%
Revenue Growth	29.64x
Revenue Growth Q	-23.02x
Revenue Growth3 Y	6.28x
Revenue Growth5 Y	20.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.1
Assets	GBX 18.1M
Cash	GBX 5.3M
Current Assets	GBX 9.9M
Current Liabilities	GBX 3.2M
Debt	GBX 3.7M
Debt Equity	GBX 0.31
Debt FCF	GBX -0.32
Equity	GBX 11.7M
Interest Coverage	-51.36
Liabilities	GBX 6.4M
Long Term Assets	GBX 8.2M
Long Term Liabilities	GBX 3.2M
Net Cash	GBX 1.6M
Net Cash By Market Cap	GBX 13.77
Net Cash Growth	-88.26%
Net Debt Equity	GBX -0.14
Tangible Book Value	GBX 9.1M
Tangible Book Value Per Share	GBX 0.03
WACC	5.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.13
Inventory Turnover	1.08
Net Working Capital	GBX 2.3M
Quick ratio	2.63
Working Capital	GBX 6.7M
Working Capital Turnover	GBX 0.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-22.34%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-98.42%
1Y total return	-87.29%
200-day SMA	2.22
3Y total return	-94.72%
50-day SMA	0.94
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.06%
All Time High	175
All Time High Change	-99.39%
All Time High Date	2005-02-21
All Time Low	0.85
All Time Low Change	25.65%
All Time Low Date	2026-01-14
ATR	0.11
Beta	0.21
Beta1y	-0.53
Beta2y	-0.13
Ch YTD	-2.91
High	1.2
High52	11.44
High52 Date	2025-05-23
High52ch	-90.66%
Low	0.87
Low52	0.85
Low52 Date	2026-05-01
Low52ch	25.65%
Ma50ch	13.86%
Price vs 200-day SMA	-51.96%
RSI	64.48
RSI Monthly	32.76
RSI Weekly	33.89
Sharpe ratio	-1.13x
Sortino ratio	-1.6
Total Return	-22.34%
Tr YTD	-2.91
Tr15y	-95.85%
Tr1m	18.67%
Tr1w	18.67%
Tr3m	1.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -16.3M
Operating margin	-622.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	494,928,592%
Net Borrowing	-978,000
Shares Insiders	16.64%
Shares Institutions	31.59%
Shares Out	1,136,402,658
Shares Qo Q	-0.09%
Shares Yo Y	22.34%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -12.7M
Average Volume	4,133,996.2x
Bv Per Share	0.04
CAPEX	GBX -369,000
Ch10y	-98.42
Ch15y	-95.85
Ch1m	18.67
Ch1w	18.67
Ch1y	-87.29
Ch20y	-98.71
Ch3m	1.71
Ch3y	-94.73
Ch5y	-99.06
Ch6m	-46.6
Change	22.06%
Change From Open	23.33
Close	0.88
Days Gap	-1.03
Depreciation Amortization	785,000
Dollar Volume	30,786,809.9
Earnings Date	2026-06-01
EBIT	GBX -16.3M
EBITDA	GBX -15.5M
EPS	GBX -0.05
F Score	2
FCF	GBX -11.6M
FCF EV Yield	-115.69x
FCF Per Share	GBX -0.01
Financing CF	-1,367,000
Fiscal Year End	December
Founded	1,994
Income Tax	GBX -725,000
Investing CF	-127,000
Is Primary Listing	1
Last Earnings Date	2025-12-10
Last Report Date	2025-06-30
Ma150	1.28
Ma150ch	-16.63%
Ma20	0.93
Ma20ch	15.46%
Net CF	-12,612,000
Next Earnings Date	2026-06-01
Open	0.87
Position In Range	60.48
Ppne	5,585,000
Price Date	2026-05-08
Ptbv Ratio	1.29
Relative Volume	10.65x
Revenue	2,624,000x
SBC By Revenue	40.97x
Share Based Comp	1,075,000
Tax By Revenue	-27.63x
Tr20y	-98.71%
Tr6m	-46.6%
Volume	28,826,601
Z Score	-10.16

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/CLBX pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/CLBX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/CLBX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+31.6%

Share of float held by funds and institutions

Insider ownership

+16.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+22.3%

Negative means the company is buying back shares.

Technical

AIM/CLBX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.5

Neutral momentum band

Price vs 200-day MA

-52.0%

50/200-day relationship not available

Beta (5Y)

0.21

Less volatile than the market

Sharpe ratio

-1.13

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/CLBX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/CLBX stock rating?

aim/CLBX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/CLBX analysis?

The full report lives at /stocks/aim/CLBX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/CLBX?

The latest report frames aim/CLBX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/CLBX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.